$5.38
0.132.38%
Last update: Nov 11, 10:45 AM
Exagen Inc
XGNNASDAQ
Exagen fell 43.0% from $9.22 to $5.26, behind the S&P 500's +9.8%. Its worst day was Nov 10 (−25.9%), and its low came Mar 30 at $2.65.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Exagen closed at its highest level of the year, 4.0% above where the year started.
+4.0% · S&P 500 +0.1%
EPS of $-0.20 beat the $-0.20 estimate on $16.6M revenue (est. $16.5M); FY revenue guidance of $70.0M–$73.0M against the $74.0M consensus.
Story events cover the past 12 months · Times ET
−3.8% · S&P 500 −0.2%
Exagen closed at its lowest level of the year, 71.3% below where the year started.
−1.1% · S&P 500 −0.3%
EPS of $-0.17 beat the $-0.25 estimate on $17.3M revenue (est. $16.4M); FY revenue guidance of $70.0M–$73.0M against the $71.2M consensus.
+34.9%, on 6M shares, the year's heaviest volume · S&P 500 +0.2%
EPS of $-0.13 beat the $-0.19 estimate on $19.9M revenue (est. $17.8M); FY revenue guidance of $72.0M–$75.0M against the $71.6M consensus.
+37.8%, the year's best day · S&P 500 +1.8%
EPS of $-0.25 missed the $-0.17 estimate on $18.4M revenue (est. $18.3M); FY revenue guidance of $72.0M–$75.0M against the $73.9M consensus.
−25.9%, the year's worst day · S&P 500 −0.4%
Where it ended: a close of $5.26 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 9, 2027 (EPS est. $-0.18, revenue est. $18.3M).
Nothing in the past 12 months.
All XGN dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XGN and SPY from Benzinga historical bars. Not investment advice.
